Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
21.00
+0.49 (2.39%)
Jun 18, 2025, 4:00 PM - Market closed
Palvella Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$46.29
Upside
+120.43%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $53 → $52 | Strong Buy | Maintains | $53 → $52 | +147.62% | May 16, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +80.95% | Apr 30, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +138.10% | Apr 9, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +80.95% | Apr 1, 2025 |
Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +114.29% | Mar 26, 2025 |
Jones Trading | Jones Trading | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +114.29% | Mar 25, 2025 |
Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +138.10% | Mar 7, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +85.71% | Feb 26, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +85.71% | Feb 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +80.95% | Feb 11, 2025 |
TD Cowen | TD Cowen | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +109.52% | Feb 5, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +80.95% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +80.95% | Jan 3, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +80.95% | Dec 26, 2024 |